Cornerstone Therapeutics, Inc. (CRTX) Posts Q2 Loss of 17c/Share
Tweet
Share
E-mailGet Alerts CRTX Hot Sheet
Price: $1.95 --0%
Financial Fact:
Interest expense, net: -1.68M
Today's EPS Names:
VAXX, NMRD, EGRX, More
Financial Fact:
Interest expense, net: -1.68M
Today's EPS Names:
VAXX, NMRD, EGRX, More
Join SI Premium – FREE
Cornerstone Therapeutics, Inc. (NASDAQ: CRTX) reported Q2 EPS of ($0.17), $0.15 worse than the analyst estimate of ($0.02). Revenue for the quarter came in at $21.47 million versus the consensus estimate of $18.84 million.
For earnings history and earnings-related data on Cornerstone Therapeutics, Inc. (CRTX) click here.
For earnings history and earnings-related data on Cornerstone Therapeutics, Inc. (CRTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ondas Holdings Inc. (ONDS) Misses Q2 EPS by 9c
- Aeroflex Holdings (ARX) Tops Q2 EPS by 15c
- Lucid Diagnostics Inc. (LUCD) Reports In-Line Q2 EPS
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
